Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 26,460 | 44,816 | 21,268 | 19,327 | 21,153 |
| Gross Profit | 26,460 | 44,816 | 21,268 | 19,327 | 21,153 |
| Operating Expenses | 164,668 | 166,619 | 124,708 | 103,650 | 76,863 |
| Operating Income | -138,208 | -121,803 | -103,440 | -84,323 | -55,710 |
| Other Income | 409 | 1,885 | 1,579 | 794 | 1,406 |
| Pre-tax Income | -137,799 | -119,918 | -101,861 | -83,529 | -54,304 |
| Income Tax | -1,763 | -1,785 | -1,121 | -1,332 | -1,526 |
| Net Income Continuous | -136,036 | -118,133 | -100,740 | -82,197 | -52,778 |
| Net Income | $-136,036 | $-118,133 | $-100,740 | $-82,197 | $-52,778 |
| EPS Basic Total Ops | -1.23 | -1.12 | -0.96 | -0.79 | -0.50 |
| EPS Basic Continuous Ops | -1.22 | -1.12 | -0.96 | -0.79 | -0.51 |
| EPS Diluted Total Ops | -1.23 | -1.12 | -0.96 | -0.79 | -0.50 |
| EPS Diluted Continuous Ops | -1.22 | -1.12 | -0.96 | -0.79 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | -1.12 | -0.75 | -0.72 | -0.66 |
| EBITDA(a) | $-130,228 | $-115,178 | $-97,751 | $-80,985 | $-51,957 |